We are excited to announce that Grove AI has successfully raised $4.9 million in our latest funding round, aimed at accelerating our innovative approach to participant recruitment and engagement in clinical research. Specializing in AI-accelerated Participant Recruitment Management (PRM), Grove AI leverages cutting-edge technology to help clinical research organizations efficiently identify, engage, and retain participants for studies at scale. This new influx of capital will not only enhance our existing platform but also enable us to expand our capabilities and integrate advanced features that respond to the evolving needs of the clinical research landscape. Our AI-driven solutions are designed to streamline the recruitment process, reducing time and costs while ensuring a diverse pool of participants, which is critical for the advancement of medical research. As the demand for effective and efficient clinical trials continues to grow, this funding will allow us to enhance our technology, grow our team, and ultimately improve the way organizations connect with potential participants. We are grateful to our investors for their confidence in our mission to transform clinical research through the power of artificial intelligence. Looking ahead, we are committed to driving innovation and ensuring that more individuals have the opportunity to contribute to groundbreaking studies that could change lives and shape the future of healthcare. Stay tuned for more updates on our journey as we continue to make strides in reshaping participant engagement in clinical research.












